Jan Drappatz

151 papers receiving 6.7k citations

Jan Drappatz's Hit Papers

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients 2007 · 1.4k citations
1.4k0+6+12Years since publication4008001.2k

Peers

Jan Drappatz
Comparison fields: 5 of 125
  • Genetics 3.2k
  • Cancer Research 1.2k
  • Neurology 960
  • Oncology 1.2k
  • Pathology and Forensic Medicine 610
Replace Randy L. Jensen with:
Randy L. Jensen United States
Annick Desjardins United States
Patrick Roth Switzerland
Ryo Nishikawa Japan
H. Ian Robins United States
Uri Tabori Canada
Jeffrey J. Raizer United States
Olivier Chinot France
Xiaobu Ye United States
Andrew D. Norden United States
Jan Drappatz relative to Randy L. Jensen United States Randy L. Jensen's profile →
Citations per field
00.5×2.8×
Randy L. Jensen · 1×
Citations per year

Countries citing papers authored by Jan Drappatz

Since Specialization
Citations

This map shows the geographic impact of Jan Drappatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Drappatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Drappatz more than expected).

Fields of papers citing papers by Jan Drappatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Drappatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Drappatz. The network helps show where Jan Drappatz may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Drappatz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Drappatz Line = papers co-authored together Jan Drappatz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.

#Work
1
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Hit paper breakdown →
20071366
2 2010410
3 2014199
4 2009196
5 2008191
6 2013146
7 2009141
8 2012135
9 2006133
10 2008131
11 2010130
12 2006126
13 2010121
14 2008112
15 2008112
16 201295
17 200792
18 201291
19 201789
20 201484

About Jan Drappatz

Jan Drappatz is a scholar working on Genetics, Oncology, Pulmonary and Respiratory Medicine, Neurology and Molecular Biology, having authored 157 papers that have together received 6.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (96 papers), Brain Metastases and Treatment (25 papers), Meningioma and schwannoma management (16 papers), Cancer, Hypoxia, and Metabolism (15 papers), Cancer Treatment and Pharmacology (14 papers), CNS Lymphoma Diagnosis and Treatment (13 papers), Histone Deacetylase Inhibitors Research (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). The work is most often cited by research in Genetics (3.2k citations), Cancer Research (1.2k citations), Neurology (960 citations), Oncology (1.2k citations) and Pathology and Forensic Medicine (610 citations). Jan Drappatz has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Patrick Y. Wen, Andrew D. Norden, Santosh Kesari, Tracy T. Batchelor, Lisa Doherty, Scott R. Plotkin, David Schiff, Dan G. Duda, Thomas Benner and David N. Louis. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Neuro-Oncology, International Journal of Radiation Oncology*Biology*Physics and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact